SUCRALFATE

Sucralfate Adverse Events Reported to the FDA Over Time

How are Sucralfate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Sucralfate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Sucralfate is flagged as the suspect drug causing the adverse event.

Most Common Sucralfate Adverse Events Reported to the FDA

What are the most common Sucralfate adverse events reported to the FDA?

Dehydration	20 (2.29%)
Weight Decreased	20 (2.29%)
Constipation	16 (1.83%)
Delirium	15 (1.72%)
Medication Error	14 (1.6%)
Visual Impairment	14 (1.6%)
Leukocytoclastic Vasculitis	13 (1.49%)
Pyrexia	13 (1.49%)
Fatigue	12 (1.37%)
Depression	11 (1.26%)
Cellulitis	10 (1.14%)
	Show More
Confusional State	10 (1.14%)
Urinary Tract Infection	10 (1.14%)
Agitation	9 (1.03%)
Decreased Appetite	9 (1.03%)
Erythema Multiforme	9 (1.03%)
Insomnia	9 (1.03%)
Lymphocyte Stimulation Test Positiv...	9 (1.03%)
Nausea	9 (1.03%)
Rash	9 (1.03%)
Diarrhoea	8 (.92%)
Disorientation	8 (.92%)
Haemoglobin Decreased	8 (.92%)
Hallucination, Visual	8 (.92%)
Incorrect Route Of Drug Administrat...	8 (.92%)
Pseudodementia	8 (.92%)
Acute Generalised Exanthematous Pus...	7 (.8%)
Gastritis	7 (.8%)
Scrotal Oedema	7 (.8%)
Vomiting	7 (.8%)
Atrial Fibrillation	6 (.69%)
Drug Exposure During Pregnancy	6 (.69%)
Drug Ineffective	6 (.69%)
Erythema	6 (.69%)
Haematocrit Decreased	6 (.69%)
Hepatic Function Abnormal	6 (.69%)
Memory Impairment	6 (.69%)
Pneumocystis Jiroveci Pneumonia	6 (.69%)
Pruritus	6 (.69%)
Abortion Induced	5 (.57%)
Anaemia	5 (.57%)
Blood Alkaline Phosphatase Increase...	5 (.57%)
Dizziness	5 (.57%)
Drug Toxicity	5 (.57%)
Gastrointestinal Haemorrhage	5 (.57%)
Intra-uterine Death	5 (.57%)
Liver Disorder	5 (.57%)
Malaise	5 (.57%)
Mental Status Changes	5 (.57%)
Oesophagitis	5 (.57%)
Protein Total Decreased	5 (.57%)
Renal Disorder	5 (.57%)
Abdominal Pain	4 (.46%)
Abdominal Pain Upper	4 (.46%)
Alanine Aminotransferase Increased	4 (.46%)
Aspartate Aminotransferase Increase...	4 (.46%)
Bezoar	4 (.46%)
Blood Aluminium Increased	4 (.46%)
Chills	4 (.46%)
Death Neonatal	4 (.46%)
Hepatitis Acute	4 (.46%)
Hypokalaemia	4 (.46%)
Hypotension	4 (.46%)
Inflammation	4 (.46%)
Maternal Drugs Affecting Foetus	4 (.46%)
Abdominal Distension	3 (.34%)
Cardiac Arrest	3 (.34%)
Cerebral Infarction	3 (.34%)
Clostridium Colitis	3 (.34%)
Condition Aggravated	3 (.34%)
Cough	3 (.34%)
Cytomegalovirus Viraemia	3 (.34%)
Death	3 (.34%)
Drug Interaction	3 (.34%)
Enteritis Infectious	3 (.34%)
Feeling Abnormal	3 (.34%)
Gamma-glutamyltransferase Increased	3 (.34%)
Headache	3 (.34%)
Joint Swelling	3 (.34%)
Lethargy	3 (.34%)
Melaena	3 (.34%)
Necrotising Fasciitis	3 (.34%)
Pain	3 (.34%)
Platelet Count Decreased	3 (.34%)
Product Quality Issue	3 (.34%)
Protein-losing Gastroenteropathy	3 (.34%)
Respiratory Failure	3 (.34%)
Shock	3 (.34%)
Sinus Bradycardia	3 (.34%)
Thrombocytopenia	3 (.34%)
Tremor	3 (.34%)
Abdominal Discomfort	2 (.23%)
Abnormal Behaviour	2 (.23%)
Anorexia	2 (.23%)
Aphasia	2 (.23%)
Atrophy	2 (.23%)
Back Pain	2 (.23%)
Blindness Cortical	2 (.23%)
Blister	2 (.23%)
Blood Bilirubin Increased	2 (.23%)
Blood Sodium Decreased	2 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Sucralfate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sucralfate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Sucralfate

What are the most common Sucralfate adverse events reported to the FDA?

Epidermal And Dermal Conditions	54 (6.18%)
Gastrointestinal Signs	36 (4.12%)
Deliria	33 (3.78%)
Hematology Investigations	32 (3.66%)
Medication Errors	32 (3.66%)
Infections - Pathogen Unspecified	29 (3.32%)
Electrolyte And Fluid Balance Condi...	28 (3.2%)
Gastrointestinal Motility And Defec...	26 (2.97%)
Physical Examination Topics	22 (2.52%)
Hepatic And Hepatobiliary	19 (2.17%)
Neurological	18 (2.06%)
	Show More
Skin Vascular Abnormalities	18 (2.06%)
Vision	17 (1.95%)
Chemical Injury And Poisoning	16 (1.83%)
Bacterial Infectious	15 (1.72%)
Cardiac Arrhythmias	15 (1.72%)
Hepatobiliary	15 (1.72%)
Gastrointestinal Inflammatory Condi...	14 (1.6%)
Respiratory	14 (1.6%)
Body Temperature Conditions	13 (1.49%)
Sleep Disorders	13 (1.49%)
Appetite And General Nutritional	12 (1.37%)
Decreased And Nonspecific Blood Pre...	12 (1.37%)
Penile And Scrotal Disorders	12 (1.37%)
Depressed Mood Disorders	11 (1.26%)
Gastrointestinal Conditions	11 (1.26%)
Therapeutic And Nontherapeutic Effe...	11 (1.26%)
Anxiety Disorders	10 (1.14%)
Disturbances In Thinking	10 (1.14%)
Gastrointestinal Hemorrhages	10 (1.14%)
Joint	9 (1.03%)
Dementia And Amnestic Conditions	8 (.92%)
Renal Disorders	8 (.92%)
Fatal Outcomes	7 (.8%)
Fungal Infectious	7 (.8%)
Mental Impairment	7 (.8%)
Renal And Urinary Tract Investigati...	7 (.8%)
Gastrointestinal Ulceration And Per...	6 (.69%)
Psychiatric	6 (.69%)
Viral Infectious	6 (.69%)
Abortions And Stillbirth	5 (.57%)
Anemias Nonhemolytic And Marrow Dep...	5 (.57%)
Cardiac And Vascular Investigations	5 (.57%)
Enzyme	5 (.57%)
Obstetric And Gynecological Therape...	5 (.57%)
Peripheral Neuropathies	5 (.57%)
Product Quality Issues	5 (.57%)
Protein And Chemistry Analyses	5 (.57%)
Toxicology And Therapeutic Drug Mon...	5 (.57%)
Water, Electrolyte And Mineral	5 (.57%)
Bone Disorders	4 (.46%)
Cardiac Disorder Signs	4 (.46%)
Central Nervous System Vascular	4 (.46%)
Inner Ear And Viiith Cranial Nerve	4 (.46%)
Lower Respiratory Tract Disorders	4 (.46%)
Skin Appendage Conditions	4 (.46%)
Tissue	4 (.46%)
Acid-base	3 (.34%)
Allergic Conditions	3 (.34%)
Bone And Joint Injuries	3 (.34%)
Gastrointestinal Stenosis And Obstr...	3 (.34%)
Headaches	3 (.34%)
Metabolic, Nutritional And Blood Ga...	3 (.34%)
Movement Disorders	3 (.34%)
Musculoskeletal And Connective Tiss...	3 (.34%)
Platelet	3 (.34%)
Urinary Tract Signs	3 (.34%)
Vascular	3 (.34%)
Embolism And Thrombosis	2 (.23%)
Encephalopathies	2 (.23%)
Gallbladder	2 (.23%)
Gastrointestinal Neoplasms Malignan...	2 (.23%)
Hearing	2 (.23%)
Investigations, Imaging And Histopa...	2 (.23%)
Lifestyle Issues	2 (.23%)
Muscle	2 (.23%)
Neonatal Respiratory	2 (.23%)
Oral Soft Tissue Conditions	2 (.23%)
Personality Disorders	2 (.23%)
Psychiatric And Behavioural Symptom...	2 (.23%)
Pulmonary Vascular	2 (.23%)
Schizophrenia And Other Psychotic	2 (.23%)
Suicidal And Self-injurious Behavio...	2 (.23%)
Tongue Conditions	2 (.23%)
Vascular Hypertensive	2 (.23%)
Vascular Inflammations	2 (.23%)
White Blood Cell	2 (.23%)
Bone, Calcium, Magnesium And Phosph...	1 (.11%)
Bronchial Disorders	1 (.11%)
Connective Tissue Disorders	1 (.11%)
Cranial Nerve Disorders	1 (.11%)
Exocrine Pancreas Conditions	1 (.11%)
External Ear Disorders	1 (.11%)
Gastrointestinal	1 (.11%)
Glaucoma And Ocular Hypertension	1 (.11%)
Heart Failures	1 (.11%)
Hematological And Lymphoid Tissue T...	1 (.11%)
Hemolyses And Related Conditions	1 (.11%)
Hepatic And Biliary Neoplasms Benig...	1 (.11%)
Injuries By Physical Agents	1 (.11%)
Lipid Analyses	1 (.11%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Sucralfate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Sucralfate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.